Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2018-07
  • Rotenone: Mitochondrial Complex I Inhibitor for Disease M...

    2026-01-05

    Rotenone: Benchmarking Mitochondrial Dysfunction in Modern Biomedical Research

    Principle Overview: What is Rotenone and How Does It Induce Mitochondrial Stress?

    Rotenone (CAS 83-79-4) is a highly potent, naturally derived mitochondrial Complex I inhibitor. By selectively blocking electron transfer within Complex I of the electron transport chain, Rotenone disrupts the mitochondrial proton gradient and impedes oxidative phosphorylation. This results in rapid ATP depletion, accumulation of NADH, and a surge in reactive oxygen species (ROS) — a signaling event central to ROS-mediated cell death and mitochondrial dysfunction in a wide array of cell types.

    As a mitochondrial dysfunction inducer, Rotenone is invaluable for modeling neurodegenerative processes, apoptosis, and autophagy pathway research. In SH-SY5Y neuroblastoma cells, it serves as a gold-standard apoptosis inducer, triggering caspase activation and distinct stress-responsive signaling via p38 MAPK and JNK pathways. In vivo, Rotenone's ability to induce dopaminergic neurite degeneration makes it a cornerstone for Parkinson's disease model development and neurodegenerative disease research.

    Step-by-Step Experimental Workflow and Protocol Enhancements

    Deploying Rotenone effectively hinges on careful preparation, solubilization, and dosing:

    1. Stock Solution Preparation

    • Solubility: Rotenone is insoluble in water and ethanol but dissolves readily in DMSO at concentrations ≥77.6 mg/mL. For most cell-based assays, a 10 mM DMSO stock is recommended.
    • Aliquoting: Prepare single-use aliquots to avoid repeated freeze-thaw cycles, which may degrade compound potency.
    • Storage: Store at <-20°C. Once dissolved, stocks are not recommended for long-term storage due to DMSO-induced hydrolysis.

    2. Cell-Based Mitochondrial Dysfunction Assays

    • Apoptosis Induction (SH-SY5Y cells): Treat differentiated SH-SY5Y cells with Rotenone at 50 nM – 2 μM. Notably, at 50 nM, Rotenone induces a biphasic survival curve over 21 days, making it ideal for chronic stress models.
    • Caspase Activation: Measure caspase-3/7 activity post-treatment to confirm apoptosis induction. For maximal sensitivity, use a 2-hour exposure at 1 μM.
    • Autophagy Pathway Research: Monitor LC3-II accumulation and p62 degradation in response to Rotenone-induced mitochondrial stress.
    • MAPK Pathway Analysis: Assess phosphorylation of p38 MAPK and JNK to map ROS-triggered kinase signaling cascades.

    3. Animal Models of Neurodegeneration

    • Parkinson’s Disease Model: Administer Rotenone intranasally or via intraperitoneal injection (dose range: 2–3 mg/kg in rodents) to induce selective dopaminergic neuron loss in the substantia nigra, recapitulating hallmark features of Parkinson’s disease.
    • Olfactory Function: Assess olfactory impairment post-Rotenone to model early non-motor symptoms of neurodegenerative disease.

    For more granular protocol details and troubleshooting, see the comprehensive guide in "Rotenone (SKU B5462): Precision in Modeling Mitochondrial...", which complements this workflow by offering actionable solutions for assay sensitivity and reliability.

    Advanced Applications and Comparative Advantages

    1. ROS-Mediated Cell Death and Metabolic Regulation

    Rotenone’s unique mode of action allows precise titration of mitochondrial stress, enabling the study of ROS-mediated cell death and metabolic adaptations. These effects are critical for dissecting the interplay between mitochondrial dysfunction and immunometabolic reprogramming—an area highlighted in recent studies of tumor-associated macrophages (TAMs). For example, in the reference study by Xiao et al. (Immunity, 2024), metabolic reprogramming via AMPKa activation and downstream STAT6 signaling was shown to shape macrophage immunosuppression in the tumor microenvironment. Rotenone can be used as a probe to model mitochondrial oxidative stress and dissect these metabolic checkpoints, offering translational value to cancer immunology research.

    2. Proteostasis and Post-translational Control

    By inducing mitochondrial stress, Rotenone enables advanced interrogation of mitochondrial proteostasis and redox signaling, extending its utility beyond classical apoptosis assays. As reviewed in "Rotenone as a Probe for Mitochondrial Proteostasis and Co...", researchers can integrate Rotenone in workflows assessing mitochondrial protein turnover, ubiquitin pathway activation, and the effects on metabolic enzyme regulation.

    3. Precision Modeling of Neurodegenerative Disease

    The reproducible degeneration of dopaminergic neurons upon Rotenone treatment makes it a preferred agent for Parkinson’s disease model creation. Compared to other mitochondrial inhibitors, Rotenone’s well-characterized IC50 (1.7–2.2 μM) and dose-dependent effects support high experimental reproducibility and sensitivity, as emphasized in "Rotenone: Mitochondrial Dysfunction Inducer for Advanced ...". Its use in chronic, low-dose paradigms uniquely enables modeling of progressive neurodegeneration and chronic metabolic stress.

    4. Integration with Immunometabolic Checkpoints

    Emerging evidence from Xiao et al. (2024) and others points to the critical role of mitochondrial metabolism in immune cell function. Rotenone provides a mechanistic handle for triggering mitochondrial stress, enabling the study of how immune cells—such as macrophages—adapt via AMPK, mTORC1, and STAT6 signaling axes. This positions Rotenone as a bridge compound linking metabolic rewiring to immunological outcomes.

    Troubleshooting & Optimization Tips

    • Solubility Issues: If Rotenone appears turbid or forms precipitate in DMSO, sonicate briefly or gently warm to 37°C before use. Avoid aqueous or ethanol-based solvents.
    • Batch Variability: Use Rotenone from APExBIO for lot-to-lot consistency; batch analysis certificates ensure reproducible IC50 and purity.
    • Assay Interference: To reduce off-target effects, titrate Rotenone doses carefully. For cell lines with high DMSO sensitivity, keep final DMSO concentration under 0.1% v/v.
    • Long-Term Storage: Prepare small aliquots; avoid repeated freeze-thaw cycles. Dissolved Rotenone is best used within 1 week at -20°C.
    • Data Quality: For robust mitochondrial stress readouts, include positive and negative controls, and validate findings using orthogonal assays such as Seahorse XF metabolic flux analysis or live-cell imaging of ROS.

    For a comparative evaluation of Rotenone to other mitochondrial stressors, and advanced troubleshooting, see "Rotenone as a Precision Mitochondrial Stressor: Mechanist...", which extends these recommendations with insights into energy stress and autophagy regulation.

    Future Outlook: Rotenone’s Expanding Role in Translational Research

    As the landscape of mitochondrial and immunometabolic research evolves, Rotenone’s ability to induce controlled mitochondrial dysfunction will remain central to both fundamental and translational studies. Future applications are likely to leverage Rotenone in combination with genetic or pharmacological modulators—such as AMPK activators or checkpoint inhibitors—to dissect cellular resilience and vulnerability. Its role in advancing our understanding of neurodegenerative disease, cancer immunology, and metabolic adaptation is poised to grow, especially as new insights emerge linking mitochondrial stress to immune cell fate (as demonstrated by Xiao et al., 2024).

    For researchers seeking a reliable mitochondrial Complex I inhibitor, Rotenone for sale from APExBIO offers unmatched purity, stability, and technical support—making it the trusted backbone for studies in mitochondrial dysfunction, apoptosis, autophagy, and neurodegenerative disease modeling.

    Conclusion

    Whether you are exploring the intricacies of caspase activation assays, investigating the autophagy pathway, or building sophisticated Parkinson’s disease models, Rotenone remains a precision tool for inducing mitochondrial stress. Its well-documented mechanism of action, reproducibility, and adaptability across systems—underscored by the expertise of APExBIO—ensure your experiments are grounded in reliability and scientific rigor. For detailed protocols, advanced troubleshooting, and related research, the resources cited herein provide a comprehensive toolkit to optimize your next study.